This article has Open Peer Review reports available.
An unusual case of congenital melanocytic nevus presenting as neurocutaneous melanoma coexisting with Tuberous Sclerosis complex: A case report
© Rai et al; licensee BioMed Central Ltd. 2011
Received: 27 September 2010
Accepted: 1 July 2011
Published: 1 July 2011
Congenital melanocytic nevi are among the several known risk factors for the development of melanoma. Neurocutaneous melanosis is a rare, congenital, non-hereditary disorder characterized by the presence of multiple and/or giant congenital melanocytic nevi. It is a rare condition, with fewer than 200 cases reported in the literature. Its association with tuberous sclerosis complex, a form of the neurocutaneous syndrome, is an unusual finding which, to the best of our knowledge, has not been documented in the English literature so far. Herein we present the first case documenting such an association in a 16-year-old post-pubertal Indian girl.
In this report, we describe the case of a 16-year-old Indian girl who presented to our hospital with swelling on the scalp which had progressed from the hairline to just above the left brow, causing mechanical ptosis. She was born with a black-pigmented triangular patch covered with hair over the scalp which had increased in size over a period of eight years after birth. An X-ray of her skull and ultrasonography revealed soft tissue swelling in the left temporofrontoparietal region. Magnetic resonance imaging of her brain showed the presence of 8.99 cm × 2.26 cm abnormal signal intensity involving the scalp, a few small tubers with cortical dysplasia in the left frontoparietal region with asymmetric dilatation, and the presence of calcified subependymal nodules within the left lateral ventricle. These findings were suggestive of tuberous sclerosis. A histopathological examination of the swelling was suggestive of congenital melanocytic nevi. The patient underwent surgery. Excision of the tumor with primary skin grafting was done, with the graft being taken from the medial aspect of the right thigh.
This case warrants further research to provide concrete evidence of an association of neurocutaneous melanoma with tuberous sclerosis complex. Research should be conducted to prove whether this is an unusual association or a new syndrome. Also, similar cases in other parts of the globe should be documented, as they would provide substantial support for such an association.
Congenital melanocytic nevi (CMN) are found in approximately 1% of newborn infants, but 90% of these nevi are very small. Giant congenital nevi (GCN), giant hairy nevi and nevocellular nevi represent a special group of melanocytic lesions that generally cover large areas of the body and carry a potential risk for the development of malignant melanoma . A congenital nevus is one of several known risk factors leading to the development of melanoma. Fortunately, melanoma remains an uncommon malignancy in pre-pubertal children, with an annual incidence of 0.7 cases per 1 million children from birth through age nine years. Patients' concern regarding changing or worrisome-looking nevi are nonetheless very common. Moreover, by the time a child reaches adolescence, the incidence of melanoma increases substantially, with a rate of 13.2 cases per one million children ages 15 to 19 years .
Neurocutaneous melanosis (NCM) is a congenital, non-hereditary disorder defined by the presence of multiple and/or GCMN associated with abnormal melanin deposits in the brain and/or leptomeninges documented by magnetic resonance imaging (MRI) or autopsy [3–6]. It is a rare condition, with fewer than 200 cases reported in the literature. Although there is proliferation of melanocytes in the skin and arachnoid matter, there is currently no embryological explanation for the genesis of this disorder. Approximately one-half of all patients with NCM eventually develop melanoma of the central nervous system . However, the presence of tuberous sclerosis complex (TSC), a form of the neurocutaneous syndrome (NCS), concurrently with NCM is an unusual and rare finding which, to the best of our knowledge, has not been documented in the literature so far. Herein we present the first such association in a 16-year-old girl.
A 16-year-old Indian girl presented to our hospital with swelling on the scalp. She was born with a black-pigmented triangular patch over the scalp covered with hair as well as multiple black hairy patches on her extremities, back, and most of her anterior trunk. The patch on the scalp had increased in size over a period of eight years after birth. Within the past three months, swelling had progressed from the hairline to just above the left brow, leading to unilateral mechanical ptosis. Upon applying pressure, there was a scanty, yellowish, non-foul-smelling discharge that was occasionally blood-stained and was associated with intense itching without any pain. Her sleep, appetite, bowel, and bladder were unaltered. Her menarche had begun at the age of 15 years, and her menstrual cycle was normal and regular. Her birth and developmental history were normal. The family history was negative for congenital nevi or melanoma.
The patient's clinical examination revealed her to be afebrile, with a pulse rate of 64 beats/minute, a respiratory rate of 16 breaths/minute, and blood pressure of 120/70 mmHg. The examination of her cardiovascular system was normal. Her cranial nerve functions were normal, and no neurological deficit was found in the limbs. The plantar response in both the limbs was flexor. There was no evidence of meningeal irritation.
The patient was referred to the Department of Neuro-ophthalmology and Otolaryngology for further assessment. Her fundoscopy and visual evoked potentials were normal. Her otorhinolaryngological evaluations were normal.
Routine blood investigations showed that her hemoglobin level was 11.6% and her total leukocyte count was 4200/mm3 with relative neutrophilia (80%). Her serum urea and electrolyte levels were normal. A lumbar puncture revealed clear cerebrospinal fluid with a normal cell count and biochemistry and no growth on culture. Her liver and kidney function tests were within normal limits. Her electrocardiogram did not show any abnormal features.
An X-ray of her skull (posteroanterior view) revealed a soft tissue swelling in the left temporofrontoparietal region. Ultrasonography of the swelling showed a large, homogeneous, hypoechoic, solid 9.4 cm × 6.8 cm × 1 cm lesion in her scalp in the left frontal region and partially extending into the parietal region on the left side. The underlying outer table of the skull and diploic spaces were normal with few hyper-reflective areas scattered throughout the lesion and distal shadowing raising clinical suspicions of tiny calcified foci. The interface between the lesion and the scalp was obscured. No significant color flow was noted on a color Doppler ultrasonogram. These findings were highly suggestive of a possible angiofibroma. Power Doppler ultrasonography showed a highly vascularized lesion.
In 1861, Rokitansky  first described NCM in a 14-year-old girl. CNM is a well-known risk factor for the eventual development of melanoma. CNM are classified as large (≥ 20 cm), medium (1.5 cm to 19.9 cm), and small (≤ 1.5 cm) nevi according to their size . The term "multiple" is used when more than three lesions are present. NCM is thought to be a result of an error occurring during morphogenesis in the neuroectoderm ; however, its exact pathogenesis is unclear. NCM is currently diagnosed according to the following criteria put forth by Kadonaga and Frieden  in 1991: (1) large and/or multiple CMN in association with meningeal melanosis or melanoma, (2) no evidence of cutaneous melanoma, except in patients with histologically benign meningeal lesions, or (3) no evidence of meningeal melanoma, except in patients with histologically benign cutaneous lesions. They also found that 66% of NCM patients had large nevi, and the remaining 34% had numerous pigmented lesions in the absence of a single, large congenital melanocytic nevus. In their study, all NCM patients had either posterior midline nevi or head and neck lesions, which suggest that the axial distribution is an important risk factor for developing NCM. Our patient also had a single, large CMN with an axial distribution over the scalp with no evidence of meningeal melanoma, but she had histologically benign cutaneous scalp lesions, pointing toward the diagnosis of NCM.
Clinically, patients may present with a mass lesion or increased intra-cranial pressure due to hydrocephalus, cranial nerve paralysis, myelopathy, convulsive seizures, and so forth . Most cases of melanoma arising within the GCN occur before puberty , with a reported incidence of 8.52% and a lifetime risk in the range of 2.3% [13–17]. Giant congenital melanocytic nevi (GMCN) occur in approximately one in 20,000 people, and about 100 cases were reported worldwide prior to 2000 [3, 18, 19]. It is recommended that GCMN be removed soon after the diagnosis because of cosmetic problems and their propensity for malignant change [10, 18, 20–23]. The neurological manifestations of NCM vary with age . Before the age of two years, the most common initial clinical signs and symptoms of NCM are related to increased intra-cranial pressure, including headache (35%), vomiting (42%), generalized seizures (48%), increased head circumference (23%), cranial nerve palsies (26%; in particular cranial nerve VI), papilledema (10%), and meningeal signs (3%) . The subset of patients with a discrete intra-cranial mass become symptomatic when they are older (mean age, 12.8 years; age range, birth to 65 years) and are more likely to develop focal seizures, localized sensorimotor deficits, difficulties with speech, or psychiatric symptoms . The prognosis for patients with symptomatic NCM is poor. Our patient was asymptomatic at the time of presentation and presented to our hospital only for aesthetic reasons.
The present case pointed toward a definite diagnosis of tuberous sclerosis complex because of two major features: calcified subependymal nodules within the body of the lateral ventricles and cortical tubers as confirmed by MRI. There was no history suggestive of TSC in her parents or siblings.
Our patient had congenital giant, hairy melanotic nevi of the skin (scalp) which had gradually progressed in size to a cutaneous scalp tumor indicative of melanoma. NCM is known to be associated with the other NCSs, such as Sturge-Weber syndrome and von Recklinghausen's disease. Associations with Dandy-Walker complex, spinal lipomas, and arachnoid cysts have also been reported [25, 26]. About 100 cases of NCM have been reported. However, the coexistence of tuberous sclerosis with NCM is an unusual finding which, to the best of our knowledge, has not been documented in the literature so far.
This case warrants further research to provide concrete evidence of an association of TSC with NCM. Research should be conducted to prove whether NCM associated with TSC is an unusual or new syndrome. Also, similar cases occurring in other parts of the globe should be documented, as they would provide substantial support for such an association. Genetic and molecular investigations with specific tumor markers should be conducted. However, in the present case, because of the paucity of facilities in the institution and the financial constraints on the patient, a detailed investigation could not be performed.
Written informed consent was obtained from the patient and the patient's next-of-kin for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
We acknowledge the contribution of Dr PK Baviskar, MBBS, MS, Professor and Head, Department of Surgery, Rural Medical College, Loni, India, and Dr SG Gandage, MD, DMRD, Professor and Head, Department of Radiodiagnosis, Rural Medical College, Loni, India, in affirming our clinical diagnosis on the basis of appropriate neuroimaging.
- Fox H: Neurocutaneous melanosis. Handbook of Clinical Neurology. Edited by: Vinken PJ, Bruyn GW. 1972, Amsterdam: North-Holland, 414-428.Google Scholar
- Krengel S, Hauschild A, Schäfer T: Melanoma risk in congenital melanocytic naevi: a systematic review. Br J Dermatol. 2006, 155: 1-8.View ArticlePubMedGoogle Scholar
- Berker M, Oruckaptan HH, Oge HK, Benli K: Neurocutaneous melanosis associated with Dandy-Walker malformation: case report and review of the literature. Pediatr Neurosurg. 2000, 33: 270-273. 10.1159/000055968.View ArticlePubMedGoogle Scholar
- Caceres A, Trejos H: Neurocutaneous melanosis with associated Dandy-Walker complex. Childs Nerv Syst. 2006, 22: 67-72. 10.1007/s00381-004-1043-y.View ArticlePubMedGoogle Scholar
- Di Rocco F, Sabatino G, Koutzoglou M, Battaglia D, Caldarelli M, Tamburrini G: Neurocutaneous melanosis. Childs Nerv Syst. 2004, 20: 23-28. 10.1007/s00381-003-0835-9.View ArticlePubMedGoogle Scholar
- Mena-Cedillos CA, Valencia-Herrera AM, Arroyo-Pineda AI, Salgado-Jiménez MA, Espinoza-Montero R, Martínez-Avalos AB: Neurocutaneous melanosis in association with the Dandy-Walker complex, complicated by melanoma: report of a case and literature review. Pediatr Dermatol. 2002, 19: 237-242. 10.1046/j.1525-1470.2002.00073.x.View ArticlePubMedGoogle Scholar
- Makkar HS, Frieden IJ: Neurocutaneous melanosis. Semin Cutan Med Surg. 2004, 23: 138-144. 10.1016/j.sder.2004.01.007.View ArticlePubMedGoogle Scholar
- Rokitansky J: Ein ausgezeichneter Fall von Pigment-mal mit ausgebreiteter Pigmentierung der inneren Hin- und Ruchenmarkshaute. Allg Wien Med Z. 1861, 6: 113-116.Google Scholar
- Heffel DF, Thaller S: Congenital melanosis: an update. J Craniofac Surg. 2005, 16: 940-944. 10.1097/01.scs.0000179751.29284.51.View ArticlePubMedGoogle Scholar
- Kadonaga JN, Frieden IJ: Neurocutaneous melanosis: definition and review of the literature. J Am Acad Dermatol. 1991, 24: 747-755. 10.1016/0190-9622(91)70115-I.View ArticlePubMedGoogle Scholar
- Díaz-Insa S, Pineda M, Bestué M, Espada F, Alvarez-Fernández E: Neurocutaneous melanosis. Rev Neurol. 1998, 26: 769-771.PubMedGoogle Scholar
- Kaplan EN: The risk of malignancy in large congenital nevi. Plast Reconstr Surg. 1974, 53: 421-428. 10.1097/00006534-197404000-00007.View ArticlePubMedGoogle Scholar
- Bittencourt FV, Marghoob AA, Kopf AW, Koenig KL, Bart RS: Large congenital melanocytic nevi and the risk for development of malignant melanoma and neurocutaneous melanocytosis. Pediatrics. 2000, 106: 736-741. 10.1542/peds.106.4.736.View ArticlePubMedGoogle Scholar
- Quaba AA, Wallace AF: The incidence of malignant melanoma (0 to 15 years of age) arising in "large" congenital nevocellular nevi. Plast Reconstr Surg. 1986, 78: 174-181. 10.1097/00006534-198608000-00004.View ArticlePubMedGoogle Scholar
- DeDavid M, Orlow SJ, Provost N: A study of large congenital melanocytic nevi and associated malignant melanoma: review of cases in the New York University registry and the world literature. J Am Acad Dermatol. 1997, 36: 409-416. 10.1016/S0190-9622(97)80217-4.View ArticlePubMedGoogle Scholar
- Ruiz-Maldonado R, Tamayo L, Laterza AM, Durán C: Giant melanocytic nevi: clinical, histopathologic, and therapeutic considerations. J Pediatr. 1992, 120: 906-911. 10.1016/S0022-3476(05)81958-4.View ArticlePubMedGoogle Scholar
- Rhodes AR, Wood WC, Sober AJ, Mihm MC: Nonepidermal origin of malignant melanoma associated with a giant congenital nevocellular nevus. Plast Reconstr Surg. 1981, 67: 782-790. 10.1097/00006534-198106000-00012.View ArticlePubMedGoogle Scholar
- Cruz MA, Cho ES, Schwartz RA, Janniger CK: Congenital neurocutaneous melanosis. Cutis. 1997, 60: 178-181.PubMedGoogle Scholar
- Barkovich AJ, Frieden IJ, Williams ML: MR of neurocutaneous melanosis. AJNR Am J Neuroradiol. 1994, 15: 859-867.PubMedGoogle Scholar
- Ahuja SR, Karande S, Kulkarni MV: Multiple giant congenital melanocytic nevi with central nervous system melanosis: a case report. Neurol India. 2003, 51: 541-543.PubMedGoogle Scholar
- Won JH, Ahn SK, Kim SC, Lee SH: Neurocutaneous melanosis. Korean J Dermatol. 1992, 30: 558-563.Google Scholar
- Kim HJ, Whang KK: Surgical treatment by curettage and dermatome in 2 cases of giant congenital melanocytic nevi. Korean J Dermatol. 1998, 36: 464-468.Google Scholar
- Chu WCW, Lee V, Chan YL, Shing MMK, Chik KW, Li CK: Neurocutaneous melanosis with a rapidly deteriorating course. AJNR Am J Neuroradiol. 2003, 24: 287-290.PubMedGoogle Scholar
- Schaffer JV, McNiff JM, Bolognia JL: Cerebral mass due to neurocutaneous melanosis: eight years later. Pediatr Dermatol. 2001, 18: 369-377. 10.1046/j.1525-1470.2001.01961.x.View ArticlePubMedGoogle Scholar
- Kadonaga JN, Barkovich AJ, Edwards MS, Frieden IJ: Neurocutaneous melanosis in association with the Dandy-Walker complex. Pediatr Dermatol. 1992, 9: 37-43. 10.1111/j.1525-1470.1992.tb00323.x.View ArticlePubMedGoogle Scholar
- Kasantikul V, Shuangshoti S, Pattanaruenglai A, Kaoroptham S: Intraspinal melanotic arachnoid cyst and lipoma in neurocutaneous melanosis. Surg Neurol. 1989, 31: 138-141. 10.1016/0090-3019(89)90328-5.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.